Novo Nordisk will be selling the new 7.2-mg dose under the brand name Wegovy HD. The FDA's decision fell under a new pilot program intended to grant certain companies improved access and quicker approvals.
The Cardiovascular Business Forty Under 40 Class of 2026 represents an accomplished group of clinicians, researchers, entrepreneurs and administrators who are redefining what cardiovascular leadership looks like under the age of 40.
A new KFF survey shows almost 10% of people who had an Obamacare Marketplace plan in 2025 decided to head into 2026 with no coverage at all. Another 28% re-enrolled but with a different—presumably lesser—plan.
Authorities said Shane Daley, 40, began making threatening calls mere hours after Brian Thompson was shot and killed outside a hotel in Manhattan. Daley awaits sentencing and faces up to five years in prison.
Though the study of AI in lung cancer screening is not new, prior research has been retrospective in nature, making it challenging to determine the impact.
The Center for Medicare and Medicaid Innovation (CMMI) has tested nearly 40 APMs, of which only two turned out to be successful, which does not bode well for meeting a 2030 deadline to transition to value-based payments.
The Trilogy Transcatheter Heart Valve System is the first TAVR device approved by the FDA to treat severe aortic regurgitation. Until now, interventional cardiologists have had to settle for the off-label use of TAVR valves built for treating aortic stenosis.
